In fact, a recent study has generated CAR T cells targeting uPAR for ovarian cancer.4 Instead of using single-chain variable fragment (scfv), they used the natural ligand (a part of uPA) of uPAR to demonstrate the efficacy of uPAR-CAR T cells against ovarian cancer cells in vitro. The gene discussed is PLAUR; the disease is ovarian carcinoma.